In the article by Mieres et al, “Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease: A Consensus Statement From the American Heart Association,” which published online June 16, 2014, and appeared in the July 22, 2014, issue of the journal (Circulation. 2014;130:350–379), corrections are needed.
On page 365, in the first column, first paragraph, text was added after the last sentence. It now reads, “…for the detection of obstructive CAD.182 In the recently published sub-study of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) trial (N=628, 235 women), vasodilator perfusion stress CMR demonstrated a higher diagnostic sensitivity for detecting CAD in both women and men when compared to vasodilator stress MPI SPECT. This was especially true for women, (88.7% vs 50.9%, respectively).182a”
On page 366, first column, third paragraph, the first sentence read, “Comparative effectiveness research….” It has been changed to read, “Additional comparative effectiveness research….”
On page 366, first column, third paragraph, a new reference was added to the second sentence. It read, “Newer research with CMR (including ETT CMR)172,194,195 is being evaluated….” It has been changed to read, “Newer research with CMR (including ETT CMR)172,182a,194,195 is being evaluated….”
On page 377, in the reference section, new reference 182a was added. It reads,
182a. Greenwood JP, Motwani M, Maredia N, Brown JM, Everett CC, Nixon J, Bijsterveld P, Dickinson CJ, Ball SG, Plein S. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the CE-MARC Trial. Circulation. 2014;129:1129–1138.
These corrections have been made to the current online version of the article, which is available at http://circ.ahajournals.org/content/130/4/350.
- © 2014 American Heart Association, Inc.